Evidence map›Paper›PMID 42738314›Full record

ArticleCancers2026

WEE1 Inhibition as a Novel Therapeutic Strategy in Cutaneous T-Cell Lymphoma.

Deniz Özistanbullu, Karola Bahrami, Monika Doll, Gabi Reichenbach, Sarah M Pöschl, Raphael Wilhelm, Henner Stege, Nadja Zöller, Lars Winkler, Manuel Jäger and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Deniz ÖzistanbulluDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-2667-6557
Karola BahramiDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0001-9911-1875
Monika DollDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Gabi ReichenbachDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Sarah M PöschlDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Raphael WilhelmDepartment of Dermatology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.ORCID 0000-0002-6854-1917
Henner StegeDepartment of Dermatology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
Nadja ZöllerDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Lars WinklerExperimental Pharmacology & Oncology Berlin-Buch GmbH, 13125 Berlin, Germany.
Manuel JägerDepartment of Dermatology, Städtisches Klinikum Karlsruhe, 76133 Karlsruhe, Germany.
Jan P NicolayDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Sven R QuistClinic of Dermatology, Helix Medical Excellence Center Mainz, 55128 Mainz, Germany.
Roland KaufmannDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Markus MeissnerDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Bastian SchillingDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Johannes KleemannDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Jindrich CinatlInterdisciplinary Laboratory for Pediatric Tumor and Virus Research, Dr. Petra Joh Research Institute, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Stefan KippenbergerDepartment of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.

Funding

Dr. Rolf M. Schwiete Stiftung 2021-015
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adavosertibAZD1775cell cyclecutaneous T-cell lymphomaDNA damage responsekinase inhibitor screenmycosis fungoidesSézary syndrometargeted therapyWEE1

Identifiers

PMID42738314
PMCPMC13565369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.